2025-08-01 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc (HIMS) based on the provided data, formatted for a concise English report with key figures upfront:

**Hims & Hers Health Inc (HIMS) Analysis**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** HIMS
*   **Company Overview:** Hims & Hers Health Inc is a telehealth company that provides personalized health and wellness solutions.
*   **HIMS Cumulative Return:** 267.07%
*   **VOO Cumulative Return:** 68.55%
*   **Spread:** 157.2 (Range: -88.4 to 288.9, Relative Spread: 65.1)

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) over the tracked period.  The current spread of 157.2 indicates a substantial outperformance. The relative spread of 65.1 suggests the current outperformance is in the upper half of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
|------------|----------|----------|---------|--------|--------|
| 2019-2021  | -46.0%   | 51.0%    | -85.0%  | 0.1    | 1.5    |
| 2020-2022  | -15.0%   | 72.1%    | -21.0%  | 0.0    | 1.4    |
| 2021-2023  | -51.0%   | 72.1%    | -71.0%  | -0.2   | 2.0    |
| 2022-2024  | 127.0%   | 78.4%    | 100.0%  | -0.3   | 5.4    |
| 2023-2025  | 262.0%   | 78.4%    | 214.0%  | -0.2   | 14.8   |

**Analysis:** The Alpha, Beta analysis reveals a company that has transitioned from periods of negative performance and high market sensitivity (Beta) to more recent periods of strong positive performance (CAGR and Alpha).  Beta values have generally been above 1, indicating higher volatility than the market, but decreasing into negative numbers in the most recent years.

**2. Recent Stock Price Movement**

*   **Current Price:** 66.18
*   **Previous Close:** 65.53
*   **Change:** 0.99
*   **5-Day Moving Average:** 61.66
*   **20-Day Moving Average:** 53.62
*   **60-Day Moving Average:** 54.25

**Analysis:** The current price is above all moving averages, suggesting an upward trend.  The price moved by 0.99 which is an increase.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3295 (Low Risk)
*   **RSI:** 78.48 (Overbought)
*   **PPO:** 3.07
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Spread Change:** +15.6 (Short-term increase)
*   **Expected Return:** -10.9% (Long-term, relative to S&P 500)

**Analysis:**  The RSI indicates an overbought condition, suggesting a potential pullback. The Market Risk Indicator is in the "Low Risk" range. The 20-day relative spread change suggests a recent surge in performance. The negative expected return suggests that long-term investment might underperform the S&P 500 from the current price.

**4. Recent News & Significant Events:**

*   **[2025-07-29]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-28]:** Analysts discussing recent performance and outlook.
*   **[2025-07-30]:** Notable stock volatility.
*   **[2025-07-31]:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news indicates active discussions, volatility, and potential impactful events influencing the stock. This warrants further investigation into the specific details of these events.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-05-05 | 0.22  | 0.59 B$     |
| 2024-11-04 | 0.35  | 0.40 B$     |
| 2024-08-05 | 0.06  | 0.32 B$     |
| 2024-05-06 | 0.05  | 0.28 B$     |
| 2025-05-05 | 0.05  | 0.28 B$     |

**Analysis:**  Both EPS and revenue generally show an upward trend, suggesting improving financial performance. Notably, there's a duplicate entry for 2025-05-05.  The most recent EPS and revenue figures are the highest in the provided dataset.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.59B   | 73.50%        |
| 2024-12-31 | $0.48B   | 76.81%        |
| 2024-09-30 | $0.40B   | 79.16%        |
| 2024-06-30 | $0.32B   | 81.30%        |
| 2024-03-31 | $0.28B   | 82.36%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE    |
|------------|----------|--------|
| 2025-03-31 | $0.55B   | 9.01%  |
| 2024-12-31 | $0.48B   | 5.46%  |
| 2024-09-30 | $0.44B   | 17.18% |
| 2024-06-30 | $0.36B   | 3.67%  |
| 2024-03-31 | $0.34B   | 3.23%  |

**Analysis:** Revenue is consistently increasing, while the profit margin is trending downwards. Equity is also increasing, and ROE fluctuates, with a recent decrease. The decrease in profit margin alongside increasing revenue may warrant further investigation.

**7. Overall Analysis:**

Hims & Hers Health Inc (HIMS) has demonstrated significant outperformance compared to the S&P 500, especially in recent periods.  Recent financials show strong revenue growth but a declining profit margin. The stock is currently in overbought territory according to RSI.  Recent news events suggest potential volatility. The expected return suggests long-term underperformance relative to the S&P 500 from the current price. Based on this data, further research is warranted to understand the drivers behind the declining profit margin and the potential impact of recent news events. The overbought condition (RSI) and negative expected return (relative to the S&P 500) should also be considered. The overall trend looks to be slowing down.
